Araris Biotech AG is a startup based in Switzerland, 2 tracked investors.
Araris Biotech AG is a startup founded in 2019 based in Switzerland. Brouky records 2 investors associated with the company.
Araris Biotech AG is a Swiss biotech spin-off from the Paul Scherrer Institute and ETH Zurich that develops proprietary peptide linker technology for antibody-drug conjugates (ADCs). Its platform enables stable, homogeneous attachment of cytotoxic payloads to antibodies to create targeted cancer therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.